![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Malignant Melanoma |
|
Free Subscription
1 Am J Ophthalmol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Malignant Melanoma is free of charge.
Corrigendum to Interferon Alpha-2a as Treatment for Primary Acquired Melanosis
With Atypia and for Primary Acquired Melanosis With Atypia Surrounding
Conjunctival Melanoma. Am J Ophthalmol. 2026;285:318-323.
Am J Ophthalmol. 2026 Aug 14:S0002-9394(26)00401.
PubMed
Adjuvant Immunotherapy for High-Risk Stage II Melanoma: Real-World Utilization
and Associated Overall Survival.
Ann Surg Oncol. 2026 Aug 11. doi: 10.1245/s10434-026-20411.
PubMed
Missed Opportunities for Neoadjuvant Immunotherapy in Melanoma: Is it Time to
Consider Ultrasound Staging for Newly Diagnosed Patients?
Ann Surg Oncol. 2026 Aug 11. doi: 10.1245/s10434-026-20382.
PubMed
Abstract available
Lifetime Risk of Cutaneous Melanoma in 185 Countries: Decomposing its Difference
From Cumulative Risk into Methodological and Longevity Effects.
Br J Dermatol. 2026 Aug 14:ljag336. doi: 10.1093.
PubMed
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced
Mucosal Melanoma.
Clin Cancer Res. 2026 Aug 13. doi: 10.1158/1078-0432.CCR-26-1089.
PubMed
Abstract available
Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer
Immunotherapy.
Clin Cancer Res. 2026;32:3573-3585.
PubMed
Abstract available
Agreement between Mohs Micrographic Surgeons and Dermatopathologists in Margin
Evaluation of Melanoma in-situ Using a Digital Pathology Platform.
J Am Acad Dermatol. 2026 Aug 14:S0190-9622(26)03315.
PubMed
Molecular Alterations in Patients of Color with Advanced Cutaneous and Unknown
Primary Melanomas.
J Am Acad Dermatol. 2026 Aug 14:S0190-9622(26)03301.
PubMed
Abstract available
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and
Trametinib in BRAF V600-Mutant Advanced Melanoma.
J Clin Oncol. 2026 Aug 12:JCO2600528. doi: 10.1200/JCO-26-00528.
PubMed
Abstract available
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced
Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III
Trial.
J Clin Oncol. 2026 Aug 11:JCO2600852. doi: 10.1200/JCO-26-00852.
PubMed
Abstract available
Antigen presentation requirements for effective cDC1-based cancer immunotherapy.
J Immunol. 2026;215:vkag198.
PubMed
Abstract available
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma
Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
J Immunother. 2026 Aug 12. doi: 10.1097/CJI.0000000000000616.
PubMed
Abstract available
Dissecting the interplay between dedicator of cytokinesis 2 and neutrophil
extracellular traps in sculpting the immune landscape and clinical outcome of
melanoma using a single-cell atlas.
Melanoma Res. 2026 Aug 12. doi: 10.1097/CMR.0000000000001129.
PubMed
Abstract available
Tele-expertise reduces time to diagnosis for cutaneous melanoma.
Melanoma Res. 2026 Aug 11. doi: 10.1097/CMR.0000000000001131.
PubMed
Abstract available
Thank you for your interest in scientific medicine.